Karpińska O et al. |
Activation of CB receptors by 2-arachidonoylglycerol attenuates vasoconstriction induced by U46619 and angiotensin II in human and rat pulmonary arteries. |
2017 |
Am. J. Physiol. Regul. Integr. Comp. Physiol. |
pmid:28356298
|
Thomas KC et al. |
Contributions of TRPV1, endovanilloids, and endoplasmic reticulum stress in lung cell death in vitro and lung injury. |
2012 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:21949157
|
Shearer JA et al. |
Detrimental effects of 2-arachidonoylglycerol on whole blood platelet aggregation and on cerebral blood flow after a focal ischemic insult in rats. |
2018 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:29351454
|
Awumey EM et al. |
Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries. |
2008 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:18375719
|
Gauthier KM et al. |
Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15528233
|
Wahn H et al. |
The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:16055511
|
Borges BC et al. |
Leptin resistance and desensitization of hypophagia during prolonged inflammatory challenge. |
2011 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:21343543
|
Monteleone AM et al. |
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa. |
2015 |
Am. J. Clin. Nutr. |
pmid:25646322
|
Jokisch V et al. |
Endocannabinoid Levels in Newborns in Relation to the Mode of Delivery. |
2015 |
Am J Perinatol |
pmid:25915139
|
Feuerecker M et al. |
Effect of an acute consumption of a moderate amount of ethanol on plasma endocannabinoid levels in humans. |
2012 May-Jun |
Alcohol Alcohol. |
pmid:22278319
|
Bisogno T et al. |
Biosynthesis of 2-arachidonoyl-glycerol, a novel cannabimimetic eicosanoid, in mouse neuroblastoma cells. |
1997 |
Adv. Exp. Med. Biol. |
pmid:9561135
|
Pertwee RG |
Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. |
2008 |
Addict Biol |
pmid:18482430
|
Savinainen JR et al. |
The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. |
2012 |
Acta Physiol (Oxf) |
pmid:21418147
|
McCarron RM et al. |
Antioxidant properties of the vasoactive endocannabinoid, 2-arachidonoyl glycerol (2-AG). |
2003 |
Acta Neurochir. Suppl. |
pmid:14753451
|
Sanson B et al. |
Crystallographic study of FABP5 as an intracellular endocannabinoid transporter. |
2014 |
Acta Crystallogr. D Biol. Crystallogr. |
pmid:24531463
|
Ma L et al. |
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment. |
2015 |
Acta Biochim. Biophys. Sin. (Shanghai) |
pmid:26058582
|
Chiou LC et al. |
Targeting the cannabinoid system for pain relief? |
2013 |
Acta Anaesthesiol Taiwan |
pmid:24529672
|
Schlosburg JE et al. |
Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation. |
2009 |
AAPS J |
pmid:19184452
|
Hermann A et al. |
2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook. |
2006 |
AAPS J |
pmid:16808043
|
|
|
|
|
pmid:
|